| Allyson Dawne Maze, CRNA | |
|
6225 N State Highway 161 Ste 200, Irving, TX 75038-2241 | |
| (864) 630-4556 | |
| Not Available |
| Full Name | Allyson Dawne Maze |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 6225 N State Highway 161 Ste 200, Irving, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255662060 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP124240 (Texas) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 083404 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Plano | Plano, TX | Hospital |
| Texas Institute For Surgery At Presbyterian Hospit | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthomed Staffing Llc | 9638429178 | 237 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Premier Anesthesia Of Huntsville A Division Of Premier Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346570355 PECOS PAC ID: 7012045685 Enrollment ID: O20100503000712 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Sanjai Isaac Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134458003 PECOS PAC ID: 0143358853 Enrollment ID: O20100517000277 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Zl Dallas Spine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790110872 PECOS PAC ID: 6507095916 Enrollment ID: O20140206000217 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Interventional Spine And Pain, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033509971 PECOS PAC ID: 8729383823 Enrollment ID: O20160229000449 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20180905000794 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Anesthesiapro Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083196711 PECOS PAC ID: 2365794294 Enrollment ID: O20181004000468 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Entity Name | Innate Pain And Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104386762 PECOS PAC ID: 7618203431 Enrollment ID: O20190731001382 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allyson Dawne Maze, CRNA 13349 Terlingua Creek Dr, Frisco, TX 75033-3233 Ph: (864) 630-4556 | Allyson Dawne Maze, CRNA 6225 N State Highway 161 Ste 200, Irving, TX 75038-2241 Ph: (864) 630-4556 |
News Archive
Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Patients with attention deficit/hyperactivity disorder have a significantly increased mortality rate, especially if they are diagnosed in adulthood, a study published in The Lancet shows.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
Dacomitinib, an irreversible, pan-epidermal growth factor receptor tyrosine kinase inhibitor, does not improve outcomes compared with the first-generation EGFR–TKI erlotinib in patients with advanced non-small-cell lung cancer, irrespective of their KRAS mutation status, finds the ARCHER 1009 study.
› Verified 4 days ago
Phillip Howard Chapman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5605 N Macarthur Blvd, Ste. 220, Irving, TX 75038 Phone: 972-714-0007 Fax: 972-714-0009 | |
Dr. Robert Louis Delillo, DNP, CRNA, NSPM-C Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 220 O Connor Ridge Blvd Ste 105, Irving, TX 75038 Phone: 214-560-2000 Fax: 214-560-2555 | |
Deborah R. Grieder, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5605 N Macarthur Blvd, Ste. 220, Irving, TX 75038 Phone: 972-714-0007 Fax: 972-714-0009 | |
Carolyn Bea Watts, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5605 N Macarthur Blvd, Ste. 220, Irving, TX 75038 Phone: 972-714-0007 Fax: 972-714-0009 | |
Brian Boone, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6225 N State Highway 161 Ste 200, Irving, TX 75038 Phone: 214-687-0001 Fax: 972-518-2100 | |
Judith A Davenport, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5605 N Macarthur Blvd, Ste. 220, Irving, TX 75038 Phone: 972-714-0007 Fax: 972-714-0009 | |
Dr. Robert Joseph Mader Jr., DNP-A, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6225 N State Highway 161 Ste 200, Irving, TX 75038 Phone: 214-687-0001 |